Dr Lorraine Nolan

Dr Lorraine Nolan, Chief Executive, Health Products Regulatory Authority  

Lorraine completed her Ph.D. and post-doctoral research in drug development at Trinity College Dublin. She has been Chief Executive of the Health Products Regulatory Authority (HPRA) since 2016. Prior to joining the HPRA, she worked for a number of years in private industry and also within the state forensic science services. 

 

Lorraine has over 20 years’ experience in working in the area of health product regulation having joined the HPRA in 2001. Since that time, she has held a number of roles at senior level within the organisation across a range of areas including inspection and authorisation of human medicines, medical devices, cosmetics and controlled substances. Prior to assuming the role of Chief Executive, Lorraine was Director of Human Products Authorisation and Registration.  

 

Lorraine is the current Chair of the Management Board of the European Medicines Agency (EMA) and is actively involved in many initiatives across the network of medicines agencies in Europe. This includes membership of the Steering Group for the EU ACT initiative Accelerating Clinical Trials in the EU (ACT EU) which aims to develop the European Union further as a competitive centre for innovative clinical research.